Immunosensors in medical diagnostics--major hurdles to commercial success.
In the last few years the format of commercial immunoassays has dramatically changed. Automated instruments running up to 180 samples per hour and dry strip or film immunochemistry products are now available. These changes have been precipitated by the need for immunoassays that require less time and skill to perform. To date, no immunosensor technology has been successfully commercialized although a few are purported to be on the brink of being released for sale. Here, B. Manning and T. Maley evaluate the major factors affecting the success of immunosensors.
Manning
B
B
Ciba Corning Diagnostics Corp, Medfield, MA 02052-1688.
Maley
T
T
D015374:Biosensing Techniques; D001709:Biotechnology; D003132:Commerce; D006801:Humans; D007118:Immunoassay / Q000379:methods*